Payment overview · 2025
General Payments
$88.38
5 reported records · 3 companies
Healthcare provider profile · identity verified
Patrick J Sheets, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · RENSSELAER, IN · NPI 1396704268
Verified facts
What the public records show
CMS Open Payments records show Patrick J Sheets, M.D. received $88.38 in general payments during 2025 across 5 reported records.
Bayer Healthcare Pharmaceuticals Inc. accounted for 42.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 5 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Creon, Linzess.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CREON as an associated drug or biological on 91561 records involving 20616 distinct recipient NPIs. Public Medicare Part D data also shows 22 claims for Creon by this doctor in 2024.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Linzess by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $37.30 | 42.2% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $33.02 | 37.4% | 2 | 2025 |
| ABBVIE INC. | Unresolved — no canonical attribution shown | $18.06 | 20.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $88.38 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $37.30 | 2 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $33.02 | 2 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $33.02 | 2 | 2025 |
Source payment records
|
|||||
| CREON Normalized: creon |
Drug | ABBVIE INC. | $18.06 | 1 | 2025 |
Source payment records
|
|||||
| LINZESS Normalized: linzess |
Drug | ABBVIE INC. | $18.06 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| CREON creon |
2025 | Creon | 2024 | 22 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| LINZESS linzess |
2025 | Linzess | 2024 | 23 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | CREON open payments reported associated product |
CMS Open Payments — General Payments 91561 supporting records · 20616 recipient NPIs · example record 1201352608 |
Creon · 2024 Exact normalized brand match · 1 Part D row |
22 | suppressed by CMS |
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 889 | 133 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 799 | 216 |
| Levothyroxine Sodium | Levothyroxine Sodium | 671 | 141 |
| Alprazolam | Alprazolam | 521 | 109 |
| Tamsulosin Hcl | Tamsulosin Hcl | 496 | 103 |
| Gabapentin | Gabapentin | 468 | 100 |
| Furosemide | Furosemide | 430 | 108 |
| Prednisone | Prednisone | 426 | 182 |
| Pantoprazole Sodium | Pantoprazole Sodium | 423 | 75 |
| Amlodipine Besylate | Amlodipine Besylate | 421 | 104 |
| Memantine Hcl | Memantine Hcl | 395 | 43 |
| Sertraline Hcl | Sertraline Hcl | 380 | 45 |
| Omeprazole | Omeprazole | 355 | 107 |
| Allopurinol | Allopurinol | 349 | 89 |
| Clopidogrel | Clopidogrel Bisulfate | 314 | 45 |
| Montelukast Sodium | Montelukast Sodium | 314 | 72 |
| Donepezil Hcl | Donepezil Hcl | 302 | 40 |
| Lisinopril | Lisinopril | 291 | 79 |
| Trazodone Hcl | Trazodone Hcl | 290 | 47 |
| Carvedilol | Carvedilol | 276 | 69 |
| Famotidine | Famotidine | 255 | 57 |
| Escitalopram Oxalate | Escitalopram Oxalate | 246 | 36 |
| Potassium Chloride | Potassium Chloride | 246 | 60 |
| Hydrochlorothiazide | Hydrochlorothiazide | 236 | 73 |
| Eliquis | Apixaban | 234 | 46 |
| Digoxin | Digoxin | 213 | 45 |
| Tramadol Hcl | Tramadol Hcl | 213 | 53 |
| Simvastatin | Simvastatin | 211 | 45 |
| Metoprolol Tartrate | Metoprolol Tartrate | 198 | 65 |
| Zolpidem Tartrate | Zolpidem Tartrate | 187 | 37 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 186 | 32 |
| Spironolactone | Spironolactone | 186 | 35 |
| Metformin Hcl | Metformin Hcl | 173 | 61 |
| Losartan Potassium | Losartan Potassium | 171 | 48 |
| Metoprolol Succinate | Metoprolol Succinate | 168 | 56 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 151 | 32 |
| Pregabalin | Pregabalin | 142 | 39 |
| Ezetimibe | Ezetimibe | 137 | 47 |
| Baclofen | Baclofen | 130 | 22 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 129 | 47 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 128 | 40 |
| Mirtazapine | Mirtazapine | 128 | 17 |
| Glimepiride | Glimepiride | 127 | 38 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 118 | 51 |
| Cefdinir | Cefdinir | 117 | 70 |
| Levofloxacin | Levofloxacin | 117 | 71 |
| Clonazepam | Clonazepam | 115 | 17 |
| Azithromycin | Azithromycin | 114 | 83 |
| Levetiracetam | Levetiracetam | 114 | 15 |
| Ropinirole Hcl | Ropinirole Hcl | 114 | 32 |
| Buspirone Hcl | Buspirone Hcl | 112 | 16 |
| Ibuprofen | Ibuprofen | 103 | 24 |
| Galantamine Hbr | Galantamine Hbr | 100 | suppressed |
| Fluconazole | Fluconazole | 94 | 48 |
| Terazosin Hcl | Terazosin Hcl | 93 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 92 | 25 |
| Celecoxib | Celecoxib | 91 | 29 |
| Trulicity | Dulaglutide | 90 | 18 |
| Duloxetine Hcl | Duloxetine Hcl | 86 | 20 |
| Meloxicam | Meloxicam | 86 | 31 |
| Tizanidine Hcl | Tizanidine Hcl | 84 | 17 |
| Xarelto | Rivaroxaban | 83 | 18 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 82 | 23 |
| Ozempic | Semaglutide | 82 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 80 | 21 |
| Ondansetron Hcl | Ondansetron Hcl | 78 | 19 |
| Olanzapine | Olanzapine | 77 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 73 | 19 |
| Metformin Hcl Er | Metformin Hcl | 72 | 24 |
| Fluoxetine Hcl | Fluoxetine Hcl | 70 | 18 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 69 | 18 |
| Mounjaro | Tirzepatide | 69 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 69 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 67 | 16 |
| Loperamide | Loperamide Hcl | 66 | 14 |
| Sucralfate | Sucralfate | 65 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 64 | 15 |
| Methylprednisolone | Methylprednisolone | 62 | 54 |
| Metoclopramide Hcl | Metoclopramide Hcl | 61 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 58 | suppressed |
| Anastrozole | Anastrozole | 57 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 52 | 12 |
| Colesevelam Hcl | Colesevelam Hcl | 51 | 12 |
| Liothyronine Sodium | Liothyronine Sodium | 51 | 18 |
| Dutasteride | Dutasteride | 50 | 11 |
| Jardiance | Empagliflozin | 50 | 13 |
| Myrbetriq | Mirabegron | 50 | 12 |
| Atenolol | Atenolol | 49 | 14 |
| Oxycodone Hcl | Oxycodone Hcl | 49 | 12 |
| Januvia | Sitagliptin Phosphate | 48 | 18 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 48 | 22 |
| Doxycycline Hyclate | Doxycycline Hyclate | 45 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 45 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 44 | 12 |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 43 | suppressed |
| Bupropion Xl | Bupropion Hcl | 41 | suppressed |
| Methotrexate | Methotrexate Sodium | 39 | suppressed |
| Metolazone | Metolazone | 39 | 14 |
| Buprenorphine Hcl | Buprenorphine Hcl | 38 | suppressed |
| Topiramate | Topiramate | 38 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 37 | 15 |
| Ramipril | Ramipril | 37 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 36 | 12 |
| Lorazepam | Lorazepam | 36 | 15 |
| Quetiapine Fumarate | Quetiapine Fumarate | 36 | suppressed |
| Diazepam | Diazepam | 35 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 35 | suppressed |
| Torsemide | Torsemide | 35 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 34 | suppressed |
| Risperidone | Risperidone | 33 | suppressed |
| Glipizide Er | Glipizide | 31 | suppressed |
| Lovastatin | Lovastatin | 31 | suppressed |
| Oxycontin | Oxycodone Hcl | 31 | suppressed |
| Scopolamine | Scopolamine | 31 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 30 | 12 |
| Divalproex Sodium | Divalproex Sodium | 30 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 29 | 12 |
| Mometasone Furoate | Mometasone Furoate | 28 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Dexamethasone | Dexamethasone | 27 | 25 |
| Farxiga | Dapagliflozin Propanediol | 27 | suppressed |
| Nystatin | Nystatin | 27 | 14 |
| Valacyclovir | Valacyclovir Hcl | 27 | 15 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 26 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 26 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 25 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 25 | suppressed |
| Latanoprost | Latanoprost | 25 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 19 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 25 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 25 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 25 | suppressed |
| Finasteride | Finasteride | 24 | 12 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 24 | suppressed |
| Acetic Acid | Acetic Acid | 23 | suppressed |
| Aripiprazole | Aripiprazole | 23 | suppressed |
| Cilostazol | Cilostazol | 23 | suppressed |
| Linzess | Linaclotide | 23 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 23 | suppressed |
| Novolog Flexpen | Insulin Aspart | 23 | suppressed |
| Creon | Lipase/Protease/Amylase | 22 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 22 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 22 | 11 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 21 | suppressed |
| Klor-Con M20 | Potassium Chloride | 21 | 11 |
| Lidocaine | Lidocaine | 21 | suppressed |
| Primidone | Primidone | 21 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 20 | suppressed |
| Methylprednisolone Acetate | Methylprednisolone Acetate | 20 | 13 |
| Ondansetron Odt | Ondansetron | 20 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 19 | suppressed |
| Lacosamide | Lacosamide | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 12 |
| Alendronate Sodium | Alendronate Sodium | 18 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Glipizide | Glipizide | 18 | suppressed |
| Roflumilast | Roflumilast | 18 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Atomoxetine Hcl | Atomoxetine Hcl | 17 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 17 | suppressed |
| Lamotrigine | Lamotrigine | 17 | suppressed |
| Metronidazole | Metronidazole | 17 | 14 |
| Naproxen | Naproxen | 17 | suppressed |
| Tiagabine Hcl | Tiagabine Hcl | 17 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 16 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 16 | 16 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 16 | suppressed |
| Carbamazepine Er | Carbamazepine | 16 | suppressed |
| Folic Acid | Folic Acid | 16 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 16 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 15 | suppressed |
| Cephalexin | Cephalexin | 15 | 12 |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Enulose | Lactulose | 15 | suppressed |
| Fentanyl | Fentanyl | 15 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 15 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 15 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Verapamil Sr | Verapamil Hcl | 15 | suppressed |
| Zaleplon | Zaleplon | 15 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 14 | suppressed |
| Entresto | Sacubitril/Valsartan | 14 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 14 | suppressed |
| Amoxicillin | Amoxicillin | 13 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 13 | suppressed |
| Humalog | Insulin Lispro | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Novolog | Insulin Aspart | 13 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 13 | suppressed |
| Pentoxifylline | Pentoxifylline | 13 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 13 | suppressed |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | suppressed |
| Clarithromycin | Clarithromycin | 12 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Phenobarbital | Phenobarbital | 12 | suppressed |
| Phenytoin | Phenytoin | 12 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Chlorthalidone | Chlorthalidone | 11 | suppressed |
| Clonidine | Clonidine | 11 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 11 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Ibu | Ibuprofen | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Meropenem | Meropenem | 11 | suppressed |
| Orphenadrine Citrate Er | Orphenadrine Citrate | 11 | suppressed |
| Paxlovid (Eua) | Nirmatrelvir/Ritonavir | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $88.38 · 5 records | Bayer Healthcare Pharmaceuticals Inc. | CREON, Kerendia, LINZESS, OTEZLA, REPATHA | 2 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Creon play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error